Advertisment

Cancer

Immunotherapy substantially increases survival of people with lymphomatoid granulomatosis: NCI study

Immunotherapy substantially increases survival of people with lymphomatoid granulomatosis: NCI study

A clinical trial showed that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis.
Advertisment
सदस्यता लें